Clearmind Medicine shares are trading higher after the company announced advancement in its proprietary MEAI- based binge behavior regulator program through the granting of patent approval in Hong Kong by the Hong Kong Patent Office.
Caleminder Inc Ordinary Shares -2.74% Pre
Caleminder Inc Ordinary Shares CMND | 1.42 1.42 | -2.74% 0.00% Pre |
Clearmind Medicine shares are trading higher after the company announced advancement in its proprietary MEAI- based binge behavior regulator program through the granting of patent approval in Hong Kong by the Hong Kong Patent Office.